Ledger.Open graph →
SEC Form D · filed August 15, 2023

Boundless Bio, Inc

Offering
$100.0M
Sold
$100.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
San Diego, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (17)

Kristina D. Burow · San Diego, CADirectorZachary D. Hornby · San Diego, CAExec · DirectorBenjamin D. Cravatt, Ph.D · San Diego, CADirectorJonathan D. Lim, M.D · San Diego, CADirectorKristina D. Burow · San Diego, CADirectorFabio D. Pucci, Ph.D · San Diego, CADirectorJakob D. Loven, Ph.D · LA JOLLA, CADirectorJennifer D. Lew · San Diego, CADirectorChristine D. Brennan, Ph.D · San Diego, CADirectorJustin W. Banulski · SAN FRANCISCO, CADirectorZachary D. Hornby · San Diego, CAExec · DirectorBenjamin D. Cravatt, Ph.D · San Diego, CADirectorFabio D. Pucci, Ph.D · San Diego, CADirectorJakob D. Loven, Ph.D · LA JOLLA, CADirectorJennifer D. Lew · San Diego, CADirectorChristine D. Brennan, Ph.D · San Diego, CADirectorJonathan D. Lim, M.D · San Diego, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗